Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Feb 07, 2024 3:55pm
107 Views
Post# 35868304

mdjbrown...what was the name of the institution where Keith

mdjbrown...what was the name of the institution where Keith Strachan was in California?  You posted the YouTube video link not to long ago.   We will see if they dip their toes in the warming waters now that Brazilian market is opened up to LABS and insiders at the DEA are saying it's basically a done deal w.r.t. descheduling.   


ps: Also don't forget that Brazil signed a very large agreement with China and it wasn't only for agricultural products.   With that said, there is no reason why China cannot import cannabinoid based pharmaceuticals from the generic drug maker in Brazil.   Point is, it's NOT just the Brazilian market, it is other South American countries including an opportunity of greater volumes exporting from Brazil to China and even other BRIC countries.    
<< Previous
Bullboard Posts
Next >>